Business Description
Kringle Pharma Inc
ISIN : JP3270790003
Share Class Description:
TSE:4884: Ordinary SharesTotal Employee Number:
17Description
Kringle Pharma Inc is engaged in the research and development of HGF (hepatocyte growth factor) protein as a therapeutic agent for intractable diseases. The Company operates in a single segment, pharmaceutical development.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.48 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -0.5 | |||||
Beneish M-Score | 8.02 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -49.2 | |||||
3-Year EBITDA Growth Rate | -14.8 | |||||
3-Year EPS without NRI Growth Rate | -25.1 | |||||
3-Year Book Growth Rate | -28.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.85 | |||||
9-Day RSI | 51.63 | |||||
14-Day RSI | 47.98 | |||||
3-1 Month Momentum % | -31.49 | |||||
6-1 Month Momentum % | -24.26 | |||||
12-1 Month Momentum % | -64.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.79 | |||||
Quick Ratio | 4.18 | |||||
Cash Ratio | 3.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.3 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -1250.01 | |||||
Net Margin % | -1260.37 | |||||
EBITDA Margin % | -1250.01 | |||||
FCF Margin % | -1034.99 | |||||
OCF Margin % | -1034.99 | |||||
ROE % | -71.07 | |||||
ROA % | -44.01 | |||||
ROIC % | -231.08 | |||||
3-Year ROIIC % | -1191.74 | |||||
ROC (Joel Greenblatt) % | -281.83 | |||||
ROCE % | -47.44 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 31.88 | |||||
PB Ratio | 2.59 | |||||
Price-to-Tangible-Book | 2.59 | |||||
EV-to-EBIT | -1.2 | |||||
EV-to-EBITDA | -1.2 | |||||
EV-to-Revenue | 14.98 | |||||
EV-to-FCF | -1.52 | |||||
Price-to-GF-Value | 0.67 | |||||
| Price-to-Net-Current-Asset-Value | 2.66 | |||||
| Price-to-Net-Cash | 4.48 | |||||
Earnings Yield (Greenblatt) % | -83.48 | |||||
FCF Yield % | -28.18 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kringle Pharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 73.023 | ||
| EPS (TTM) (円) | -130.14 | ||
| Beta | 0.0651 | ||
| 3-Year Sharpe Ratio | -0.17 | ||
| 3-Year Sortino Ratio | -0.25 | ||
| Volatility % | 46.73 | ||
| 14-Day RSI | 47.98 | ||
| 14-Day ATR (円) | 19.640508 | ||
| 20-Day SMA (円) | 320.3 | ||
| 12-1 Month Momentum % | -64.03 | ||
| 52-Week Range (円) | 287 - 870 | ||
| Shares Outstanding (Mil) | 8.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kringle Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kringle Pharma Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kringle Pharma Inc Frequently Asked Questions
What is Kringle Pharma Inc(TSE:4884)'s stock price today?
The current price of TSE:4884 is 円332.00. The 52 week high of TSE:4884 is 円870.00 and 52 week low is 円287.00.
When is next earnings date of Kringle Pharma Inc(TSE:4884)?
The next earnings date of Kringle Pharma Inc(TSE:4884) is .
Does Kringle Pharma Inc(TSE:4884) pay dividends? If so, how much?
Kringle Pharma Inc(TSE:4884) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Kringle Pharma Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers